Navigation Links
CrystalGenomics Announces Positive Results from Phase 2b Osteoarthritis Study of CG100649
Date:4/18/2012

SEOUL, South Korea, April 18, 2012 /PRNewswire/ -- CrystalGenomics, Inc., a biopharmaceutical company headquartered in Korea, has just announced positive results from the Phase 2b osteoarthritis (OA) study of the CG100649, CrystalGenomics' next-generation NSAID candidate. The study met its primary and secondary endpoints which were to evaluate the safety, analgesic efficacy and functional benefits of CG100649 (2 mg or 4 mg per day) versus Celebrex® (celecoxib) (200 mg per day) over the 4 week treatment period.

This Phase 2b study was a double-blind, randomized, multicenter, non-inferiority, repeat dose study of CG100649 versus Celebrex in OA patients. Following a 5-14 day washout from all prior pain medications except paracetamol (acetaminophen), subjects recording moderate to severe hip or knee OA pain of 4 to 8 on a 0-10 numerical rating scale were randomized into the study. All subjects received 28 daily doses of either CG100649 2 mg or 4 mg, or Celebrex 200 mg. Anti-arthritic efficacy was evaluated using the standardized WOMAC OA Index and the WOMAC subscales of pain, stiffness, and physical function. The primary efficacy outcome was determined by measuring the change in the average WOMAC-Pain subscale in the index joint at Day 28 vs. Baseline. Secondary efficacy outcomes included the change in the WOMAC Pain at Days 7, 14, 21, 35, and 42; changes in the total WOMAC OA Index at Days 14, 28, and 42, changes in the WOMAC Stiffness & Physical Function subscales at Days 14, 28, and 42; and Subject's Global Assessment and Physician's Global Assessment of OA pain at Days 1, 14, 28 and 42. Throughout the study, both of the CG100649 treatment groups demonstrated non-inferiority compared to Celebrex on all primary and secondary outcome measures.

There were no drug-related serious adverse events (SAEs) in either of the CG100649 treatment groups or in the Celebrex treatment group. Similar non-serious adverse events (AEs) were observed in the CG100
'/>"/>

SOURCE CrystalGenomics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. CrystalGenomics Completes Phase I MAD Study of its Novel Antibiotic Candidate CG400549, and Prepares for Phase II Clinical Study
2. CrystalGenomics Announces Successful Completion of a Phase I SAD Clinical Trial for CG400549, its Novel Antibiotic Candidate
3. Pinnacle Biologics Inc. Announces Appointment of Bioprojet Pharma as Exclusive Distributor in Select European Countries
4. Stemline Therapeutics Announces Two Presentations of Direct Injection Synthetic Peptide Vaccine for Brain Cancer, Now Being Developed as SL-701, at the Annual Meeting of the American Association of Cancer Research (AACR)
5. Akorn, Inc. Announces First Quarter 2012 Earnings Release and Conference Call Information
6. Tengion Announces IND Filing for Neo-Kidney Augment Expected During First Half of 2013
7. ConvaTec Healthcare Announces 2011 Year-end Earnings Call
8. The Galien Foundation Announces Prix Galien USA Awards Committee, Chaired by Dr. P. Roy Vagelos
9. Morphotek®, Inc. Announces Initiation of MORAb-004 Phase 2 Study in Metastatic Colorectal Cancer
10. Sangamo BioSciences Announces Presentation at the Future Leaders in the Biotech Industry Conference
11. Gamma Pharmaceuticals, Inc. Announces Distribution Agreement for New York Tri-state Area and Purchase Order for Gamma Energy GEL™
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... China South 2015 came to a successful conclusion on April ... South has been recognized by industry insiders through its professional ... the medical device manufacturing industry in Southern China ... the successful return of the MEDTEC brand to Shenzhen ... in 2005. , The ...
(Date:6/3/2015)... Genoa has received ... two pharmacy organizations with proven track records for excellent ... strong reputations for outstanding customer service, flexibility and delivering ... Genoa is the leading provider of pharmacy ... affiliated with managing the cost and quality of their ...
(Date:6/3/2015)... , June 02, 2015 Research and ... the "Global Pharmaceutical Packaging Market 2015-2019" report ... market to grow at a CAGR of 5.9% over ... witnessed in the market is the rise in demand ... slated for the second highest growth among all the ...
Breaking Medicine Technology:MEDTEC Successfully Returns to Southern China 2MEDTEC Successfully Returns to Southern China 3Genoa, a QoL Healthcare Company Acquires Northeast Pharmaceuticals, Inc. 2Global Pharmaceutical Packaging Market 2015-2019 with Amcor, Bemis Healthcare Packaging, Gerresheimer, MeadWestvaco, Owens-Illinois & West Pharmaceutical Services Dominating 2
... CHAPEL HILL, N.C., April 10, 2012  TSI Healthcare ... practices had attested to successfully meeting "Meaningful Use" ... Records (EHR) Systems. These providers completed data collection ... 1 reporting period for the Federal Government sponsored ...
... CreatiVasc Medical has been selected as one of ... Innovation Pathway program that uses collaboration with innovators ... safeguarding patient safety. The company has ... the Hemoaccess Valve System®, which has the potential ...
Cached Medicine Technology:TSI Healthcare Customers Receive Government Incentives for Meeting EHR Requirements 2FDA Selects CreatiVasc For New Innovation Pathway Program 2
(Date:6/3/2015)... Wallingford, CT (PRWEB) June 03, 2015 ... devices, announces today since June has been designated as ... Company commends the Tucson, AZ. Police Department for its ... that its personnel utilized their Individual First Aid Kits ... help civilians involved in shootings, stabbings or traffic accidents. ...
(Date:6/3/2015)... 03, 2015 Sitting at a computer ... in the back, neck, shoulders and/or wrists. This can ... In addition, recent research links sitting for long periods ... diseases. Fortunately, three inventors from Oakville, Ontario, are offering ... desk. , They have developed a prototype for a ...
(Date:6/3/2015)... June 03, 2015 Implant design can ... osseointegration processes that unites bone to an implant surface. ... has been designed to encourage bone regeneration, resulting in ... of stable surrounding soft tissues for more esthetic restorations. ... Product Manager at MIS Implants. The triangular neck of ...
(Date:6/3/2015)... ON (PRWEB) June 03, 2015 On ... a Marketing Authorization (MA), effective immediately, which now permits ... foods that contain oats as ingredients. The MA is ... being developed. All stakeholders should be aware that, unlike ... in the USA, there are restrictions for gluten-free oat ...
(Date:6/3/2015)... Unfortunately, a majority of shoes sold are not up to ... users throughout the year. Be it a pair of shoes ... the makers generally tend to put all of their focus ... and health. To counter this problem and provide a solution ... Technologies have come up with uGALE, an insole that not ...
Breaking Medicine News(10 mins):Health News:Z-Medica Commends Tucson Police Department for Trauma Kit Utilization 2Health News:Adjustable Height Tabletop Unit Invented by Three InventHelp® Clients (TOR-9278) 2Health News:MIS Implants Launches Radically New V3 Dental Implant For Immediate Biological Benefits 2Health News:Health Canada Allows For Conditional Use Of Gluten-Free Oats 2Health News:Health Canada Allows For Conditional Use Of Gluten-Free Oats 3Health News:Vay Technologies Launches uGALE the High Tech Insole Technology for Shoes on KickStarter 2Health News:Vay Technologies Launches uGALE the High Tech Insole Technology for Shoes on KickStarter 3
... control for people with type 2 diabetes who have not ... taken in addition to the baseline insulin administered throughout the ... body of published research. br>,People who use insulin to ... insulin at mealtimes to regulate the glucose response to food. ...
... BAY) and Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced ... (sorafenib) tablets has been submitted to the U.S. ... patients with hepatocellular carcinoma (HCC), the most common form ... in more than 50 countries for the treatment of ...
... a bacterium that causes deadly Hib pneumonia and meningitis, ... ,A new study from Bangladesh published ... showed that routine immunization of infants with a Hib ... and approximately 90% of Hib meningitis cases. A similar ...
... pipes to smoke tobacco are waging an 11th-hour bid for ... in England on Sunday. ,Without the shisha, ... dozens of restaurants will lose their main appeal to tourists, ... ,"It's a disaster, we don't know what to do ...
... 105-year-old exile who was detained for 30 years in his native ... citizen at a ceremony in Miami. ,Now, he ... ,And the former fisherman is convinced he will outlive the ... ,"He's far less healthy than I am, he can hardly ...
... wife's baby after doctors refused to touch the HIV-positive woman, ... India's NDTV news channel he carried out the delivery as ... state of Uttar Pradesh shouted instructions from a distance. ... asked me to pull out the baby and cut the ...
Cached Medicine News:Health News:Inhaled Insulin for Type 2 Diabetes Shows Mixed Results 2Health News:Inhaled Insulin for Type 2 Diabetes Shows Mixed Results 3Health News:Bayer and Onyx Submit Supplemental New Drug Application for Nexavar to Treat Liver Cancer 2Health News:Hib Vaccination can Prevent Pneumonia 2Health News:Hib Vaccination can Prevent Pneumonia 3Health News:Shisha Owners Mobilise Against July 1 Smoking Ban in England 2Health News:Shisha Owners Mobilise Against July 1 Smoking Ban in England 3Health News:The American Dream Comes True for 105-year-old Cuban 2Health News:Indian Doctors Refuse to Help HIV-positive Woman Deliver: Report 2
A major advancement in the management of Pelvic Fracture Care, permitting rapid stabilization and surgical access....
The large External Fixator consists of rods, clamps, and pins. It has multiple external fixation frames, independent pin placement, and MR safe clamps. The modular frame construction permits fracture...
The Pinless Fixator can be applied quickly and easily in the OR or ER to stabilize the fracture and soft tissues without invading the medullary canal, minimizing the risk of infection associated with...
... The Hoffmann® II Compact™ Upper extremity ... anatomy of the distal radius by allowing ... planes. One of the main goals has ... while providing total versatility and ease of ...
Medicine Products: